XM does not provide services to residents of the United States of America.
P
P

Philips

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Philips And Dutch Isala Hospital Renew Long-Term Partnership

BRIEF-Philips And Dutch Isala Hospital Renew Long-Term Partnership Aug 13 (Reuters) - Koninklijke Philips NV PHG.AS : PHILIPS AND DUTCH ISALA HOSPITAL RENEW LONG-TERM PARTNERSHIP FOCUSED ON INNOVATION AND AFFORDABLE, SUSTAINABLE HEALTHCARE NEW AGREEMENT WILL LAST FOR FIVE YEARS, WITH AN OPTION TO EXTEND FOR ANOTHER FIVE YEARS Source text for Worksp
P

Philips To Repurchase Shares Up To EUR 125 Mln For Long-Term Incentive Plans

BRIEF-Philips To Repurchase Shares Up To EUR 125 Mln For Long-Term Incentive Plans Aug 5 (Reuters) - Koninklijke Philips NV PHG.AS : PHILIPS TO REPURCHASE SHARES FOR UP TO EUR 125 MILLION TO COVER LONG-TERM INCENTIVE PLANS PHILIPS EXPECTS TO TAKE DELIVERY OF FORWARD SHARE PURCHASES IN 2026 AT THE CURRENT SHARE PRICE, THIS REPRESENTS A TOTAL OF APPR
P

Siemens Healthineers misses Q3 forecasts due to slow China

UPDATE 2-Siemens Healthineers hit by China order delays in Q3, but sees 2025 turnaround Writes through with shares, CEO and CFO comments from call By Marleen Kaesebier and Louis van Boxel-Woolf July 31 (Reuters) - German medical technology company Siemens Healthineers SHLG.DE said on Wednesday its sales were hit by continued order delays in China in the third quarter, sending its shares more than 6% lower.
P
S

Euronext, Pearson, Saint-Gobain

EUROPE RESEARCH ROUNDUP- Euronext, Pearson, Saint-Gobain July 30 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Euronext, Pearson and Saint-Gobain on Tuesday. HIGHLIGHTS * Adyen NV ADYEN.AS : HSBC cuts target price to EUR 1600 from EUR 1900 * Deutsche Boerse AG DB1Gn.DE : JP Morgan raises target price to EUR 198 from EUR 194 * Euronext NV ENX.PA : JP Morgan cuts target price to EUR 107 from EUR 108 * Pearson PSON.L : JP Morgan cut
A
C
C
D
D
E
E
H
H
L
L
P
P
P
R
S
S
S
A
D
J
S

U.S. STOCKS Ventyx Biosciences, McDonald's, Pinterest

BUZZ-U.S. STOCKS ON THE MOVE-Ventyx Biosciences, McDonald's, Pinterest Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 rose on Monday, buoyed by megacap stocks as investors awaited Big Tech results, a Federal Reserve policy decision and crucial labor numbers this week.
A
A
A
N
P
T
O
U
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.